Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Mark A Buthman is Director at IDEX Corporation. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 8, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
Mark A Buthman has no open-market purchase on record since 2006. Sales in 8 of the 21 years since 2006.
Mark A Buthman reported 0 open-market purchases and 24 sales since 2006; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2015 | — | $8.8M4×4 trades |
| 2014 | — | $2.17M2×2 trades |
| 2013 | — | $4.34M2×2 trades |
| 2012 | — | $21.7M5×5 trades |
| 2011 | — | $5.41M2×2 trades |
| 2009 | — | $4.65M7×7 trades |
| 2007 | — | $1.81M1×1 trade |
| 2006 | — | $504K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
May 6, 2026805disclosed May 8
DetailsOfficial recordWest Pharmaceutical ServicesWST
May 4, 2026791disclosed May 6
DetailsOfficial recordAs of the latest filing on , Mark A Buthman reported holding 44,309 shares of West Pharmaceutical Services (WST), worth about $17.9M at the last close of $404 (Nov 18, 2026). Holdings are also on file at IDEX Corporation (IEX); together they are worth about $20.2M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| West Pharmaceutical Services WST | 44,309 | 44K direct | $404 | $17.9M | May 4, 2026 |
| IDEX Corporation IEX | 10,025 | 10K direct | $233 | $2.34M | May 6, 2026 |
Is this Mark A Buthman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated May 4, 2026, Mark A Buthman reported holding 44,309 shares of West Pharmaceutical Services (WST). At the last close of $404 on Nov 18, 2026, that is about $17.9M. This is the stake disclosed in filings, not a net worth.
No public filing gives Mark A Buthman's net worth. What SEC Form 4 shows is the stock stake: 44,309 shares of West Pharmaceutical Services (WST), about $17.9M at the last close, plus holdings in 1 other company, about $20.2M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Mark A Buthman has no open-market purchase on record since 2006. Sales in 8 of the 21 years since 2006.
In SEC filings since 2006: no open-market purchase is on record; the latest open-market sale is from 2015.
Kimberly-Clark (KMB), from 2006 to 2015: 0 purchases and 24 sales.
Mark A Buthman reported 0 open-market purchases and 24 sales here, 2006 to 2015.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.